Clinical Trials Logo

Glycemic Index clinical trials

View clinical trials related to Glycemic Index.

Filter by:

NCT ID: NCT01516333 Completed - Glycemic Index Clinical Trials

Replace Glycemic Load and Satiety Study

Start date: February 2007
Phase: Phase 1
Study type: Interventional

The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.

NCT ID: NCT01271829 Completed - Satiety Clinical Trials

Incorporating Avocados in Meals

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of incorporating avocados in meals on post-ingestion glycemic index, insulin response, sensations of satiety and on appetite-related gastrointestinal peptide and hormone release. Also the effect of consuming avocado containing meals on the caloric intake of participants in subsequent eating episodes will be explored. Each subject will participate in one intervention for one day, wait one or two weeks, come for another intervention, wait one or two weeks and come for a final intervention- three in total. Participants will be randomly assigned to one of six treatment sequences. Postprandial response to the control and two avocado-containing test meals will be assessed and compared using a 3 x 3 single blind cross-over design. The Subjects will be between 25 and 60 years old, female or male, with a BMI of 23 to 32, stable weight, no sports involvement, non-smoking and not dependent on caffeine. Thirty subjects will be recruited.

NCT ID: NCT00936754 Completed - Glycemic Index Clinical Trials

Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human

ICAST
Start date: July 2009
Phase: Phase 1
Study type: Interventional

The primary endpoint of this trial will be to evaluate the safety of a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a test meal. The secondary endpoint of this trial will be to evaluate if a single administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and insulinemia.